Treatment of schizophrenia.
Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.
Treatment of moderate to severe manic episode.
In patients whose manic episode has responded to Olanzapine treatment, Olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder
Use on children 13 – 17 years must be very careful and under the strict supervision of a physician.

This is only the preview. Please check here for the full indication.

Anatomical Therapeutic Chemical: N
Dosage form: Film coated tablet
Packaging: 10's x 10
Therapeutic area: Active pharmaceutical ingredient: